Committee Charters

Award
Chair, Mara G. Aspinall, Genzyme Corporation
The Award Committee oversees the annual PMC Leadership Award, responsible for managing recipient nomination and election. The Award recognizes the contributions of a visionary individual whose actions in science, business, and/or policy have advanced the frontier of personalized medicine.

Clinical Science
Chair, Dr. Charis Eng, MD, PhD, FACP
The Clinical Science Committee was created to evaluate the emerging applications of science and technology in personalized medicine. It serves as an advisory resource for the PMC, and helps guide policies and statements by the organization in its effort to advance personalized medicine in the public sphere. The Committee also oversees material published on the PMC's web sites and in its other publications. It will be staffed by Jerry Goldsmith, who is retiring from his position as Vice President for marketing programs at AACC (American Association for Clinical Chemistry), who has published over 280 peer reviewed studies in clinical cancer genetics and cancer genomic medicine, is Professor and Vice Chairman of the Department of Genetics at Case Western Reserve University and holds joint appointments as Professor of Molecular Medicine at the Cleveland Clinic Lerner College of Medicine and its Taussig Cancer Institute. She is also a practicing genomic medicine physician. The recipient of numerous awards, she is Senior Editor of Cancer Research; and Associate Editor of both the Journal of Clinical Endocrinology and Metabolism and of the American Journal of Human Genetics. She serves on the boards of the American Society of Human Genetics and the National Human Genome Research Institute.

Communications/Program
Co-Chair, Randy Burkholder, PhRMA
Co-Chair, Phyllis Whiteley, Ph.D., 5AM Ventures
The Communications/Program Committee assumes responsibility for overseeing the policies that govern the PMC’s efforts to provide information about personalized medicine to target constituencies and the media. It provides strategic communications counsel to the organization and helps promote the goals and programs of the PMC through all appropriate communications channels. The Committee also coordinates and organizes the PMC educational programs on topics of concern and relevance to the advancement of personalized medicine.

Finance
Chair, Brett Davis, IBM Healthcare and Life Sciences
The Finance Committee assumes responsibility for overseeing the fiscal management of the PMC, including its annual budget and compliance with all laws and regulations governing the organization.

Membership
Chair, Patrick Terry, Genomic Health, Inc.
The Membership Committee oversees the recruitment of new members, including policies related thereto, and serves also as the PMC's board nominating committee.

Public Policy
Chair, Robert Wells, HealthFutures, LLC
The Public Policy Committee governs, under a set of rules previously established by the PMC Board, the adoption of all of the organization's public policy positions, and oversees the strategies by which they are communicated to target audiences, including all branches of the federal government as well as other non-governmental agencies.

Strategic Planning
Chair, Denny Van Liew, Pfizer Inc
The Strategic Planning Committee establishes priorities for the PMC, sets the organization's long-term goals, and oversees the overall management of the PMC.

Involvement on PMC committees is open to all dues-paying members.
Participation on multiple committees from individual companies and institutions is encouraged.